About this Journal Submit a Manuscript Table of Contents
Cholesterol
Volume 2010 (2010), Article ID 723289, 9 pages
http://dx.doi.org/10.1155/2010/723289
Review Article

Alternative Perspectives: How Chinese Medicine Understands Hypercholesterolemia

1Department of Medicine, Monash University, Prahran, VIC 3800, Australia
2Faculty of Health, Engineering & Science, Victoria University, P.O. Box 14428, Melbourne, St Albans, VIC 8001, Australia

Received 17 March 2010; Revised 29 May 2010; Accepted 9 June 2010

Academic Editor: Jan Wouter Jukema

Copyright © 2010 Kylie A. O'Brien. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. O’Brien and C. C. L. Xue, “The theoretical framework of Chinese medicine,” in A Comprehensive Guide to Chinese Medicine, P.-C. Leung, C. C. L. Xue, and Y.-C. Cheng, Eds., World Scientific, River Edge, NJ, USA, 2003.
  2. V. Scheid, Chinese Medicine in Contemporary China. Plurality and Synthesis, Duke University Press, London, UK, 2002.
  3. G. Maciocia, The Foundations of Chinese Medicine, Churchill Livingstone, New York, NY, USA, 1989.
  4. H. Beinfield and E. Korngold, Between Heaven and Earth. A Guide to Chinese Medicine, Ballantine Books, New York, NY, USA, 1991.
  5. Y. H. Zhang and K. Rose, A Brief History of Qi, Paradigm Publications, Brookline, Mass, USA, 2001.
  6. J. Cai, G. Chao, D. Chen, et al., Eds., Advanced Textbook on Traditional Chinese Medicine and Pharmacology. Vol. I, State Administration of Traditional Chinese Medicine, New World Press, Beijing, China, month 1995.
  7. J. Li-Ling, “The Jing-Mai connections of the heart,” International Journal of Cardiology, vol. 89, no. 1, pp. 1–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Maoshing, The Yellow Emperor's Classic of Medicine-A New Translation of the Neijing Suwen with Commentary, Shambala, Boston, Mass, USA, 1995.
  9. P. Davidson, K. Hancock, D. Leung, E. Ang, E. Chang, D. R. Thompson, and J. Daly, “Traditional Chinese Medicine and heart disease: what does Western medicine and nursing science know about it?” European Journal of Cardiovascular Nursing, vol. 2, no. 3, pp. 171–181, 2003. View at Publisher · View at Google Scholar
  10. K. A. O'Brien and R. Z. Luo, “Myocardial ischaemia: causes, symptoms and treatment,” in Chinese Medicine Perspectives on Myocardial Ischaemia, Nova Science Publishers, New York, NY, USA, 2010.
  11. J. Hou, Traditional Chinese Treatment of Cardiovascular Disease, Academy Press, Beijing, China, 1995.
  12. S. Becker, B. Flaws, and R. Casanas, The Treatment of Cardiovascular Disease with Chinese Medicine, Blue Poppy Press, Boulder, Colo, USA, 2005.
  13. Drug Policy Bureau of Ministry of Health, “New Drug (Chinese Medicine) Pre-Clinical Research Guidelines,” Ministry of Health, Beijing, China, 1993.
  14. Y. Fu, “Clinical assessment of hypercholesterolaemia,” Chinese Journal of Information on Traditional Chinese Medicine, vol. 6, no. 8, p. 74, 1999.
  15. V. Scheid, “Shaping Chinese medicine: two case studies from contemporary China,” in Innovation in Chinese Medicine, E. Hsu, Ed., Cambridge University Press, Cambridge, UK, 2001.
  16. K. A. O'Brien, E. Abbas, J. Zhang, Z.-X. Guo, R. Luo, A. Bensoussan, and P. A. Komesaroff, “An investigation into the reliability of Chinese medicine diagnosis according to eight guiding principles and Zang-Fu theory in Australians with hypercholesterolemia,” Journal of Alternative and Complementary Medicine, vol. 15, no. 3, pp. 259–266, 2009. View at Publisher · View at Google Scholar · View at PubMed
  17. D. Bensky and A. Gamble, Chinese Herbal Materia Medica, Eastland Press, Seattle, Wash, USA, 1993.
  18. G. Valli and E.-G. V. Giardina, “Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects,” Journal of the American College of Cardiology, vol. 39, no. 7, pp. 1083–1095, 2002. View at Publisher · View at Google Scholar
  19. W. Kong, J. Wei, and J. Wei, “Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins,” Nature Medicine, vol. 10, no. 12, pp. 1344–1351, 2004. View at Publisher · View at Google Scholar · View at PubMed
  20. W. H. Frishman, S. T. Sinatra, and M. Moizuddin, “The use of herbs for treating cardiovascular disease,” Seminars in Integrative Medicine, vol. 2, no. 1, pp. 23–35, 2004. View at Publisher · View at Google Scholar
  21. W. X. Chen, G. S. Diao, W. J. Jiang, and L. T. Liang, “The influence of jue ming zi on mice with high cholesterol,” Journal Chinese Herbal Medicine, p. 72, 1989.
  22. H.-W. Yue and X.-Q. Hu, “The medicinal value of Radix Puerariea and Puerarin in treating diseases of the cardiovascular system,” Chinese Journal of Integrative Medicine, vol. 3, no. 3, pp. 234–238, 1997.
  23. W. H. Ren, G. Q. Huang, D. M. Xu, et al., “Research on the effect of pu huang and its preparations on hypercholesterolemia and the function of macrophages,” Shanghai Zhong Yi Yao Za Zhi, vol. 8, pp. 46–48, 1989.
  24. H. P. Wu, Y. L. Hua, P. L. Xi, et al., “Anti-oxidant effect of ming dang shen in rats with hypercholesterolemia,” Journal of Nanjing TCM College, vol. 10, no. 4, pp. 33–34, 1994.
  25. Q. Luo, Y. Cai, J. Yan, M. Sun, and H. Corke, “Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum,” Life Sciences, vol. 76, no. 2, pp. 137–149, 2004. View at Publisher · View at Google Scholar · View at PubMed
  26. A. Kurcok, “Ischaemia and reperfusion-induced cardiac injury: effect of two flavonoid containing plant extracts possessing radical scavenging properties,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 345, supplement, article R81, 1992.
  27. R. T. Ackermann, C. D. Mulrow, G. Ramirez, C. D. Gardner, L. Morbidoni, and V. A. Lawrence, “Garlic shows promise for improving some cardiovascular risk factors,” Archives of Internal Medicine, vol. 161, no. 6, pp. 813–824, 2001. View at Scopus
  28. C. Silagy and A. Neil, “Garlic as a lipid lowering agent—a meta-analysis,” Journal of the Royal College of Physicians of London, vol. 28, no. 1, pp. 39–45, 1994. View at Scopus
  29. C. Stevinson, M. H. Pittler, and E. Ernst, “Garlic for treating hypercholesterolemia: a meta-analysis of randomize clinical trials,” Annals of Internal Medicine, vol. 133, no. 6, pp. 420–429, 2000. View at Scopus
  30. S. Warshafsky, R. S. Kamer, and S. L. Sivak, “Effect of garlic on total serum cholesterol: a meta-analysis,” Annals of Internal Medicine, vol. 119, no. 7, pp. 599–605, 1993. View at Scopus
  31. H. K. Berthold and T. Sudhop, “Garlic preparations for prevention of atherosclerosis,” Current Opinion in Lipidology, vol. 9, no. 6, pp. 565–569, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. H. A. W. Neil, C. A. Silagy, and C. A. Silagy, “Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis,” Journal of the Royal College of Physicians of London, vol. 30, no. 4, pp. 329–334, 1996. View at Scopus
  33. C. Y. Gao, Y. J. Xu, T. Lu, et al., “Effect of da suan su on plasma and arterial wall camp in rabbits with experimental hypercholesterolemia,” Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe Zazhi, vol. 11, no. 4, pp. 227–228, 1991 (Chinese).
  34. A. N. Orekhov, V. V. Tertov, I. A. Sobenin, and E. M. Pivovarova, “Direct anti-atherosclerosis-related effects of garlic,” Annals of Medicine, vol. 27, no. 1, pp. 63–65, 1995. View at Scopus
  35. A. N. Orekhov and J. Grunwald, “Effects of garlic on atherosclerosis,” Nutrition, vol. 13, pp. 656–663, 1997.
  36. K. Prasad, S. V. Mantha, J. Kalra, and P. Lee, “Prevention of hypercholesteroemic atherosclerosis by garlic, an antioxidant,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 2, pp. 309–320, 1997.
  37. D. J. Maron, G. P. Lu, and G. P. Lu, “Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial,” Archives of Internal Medicine, vol. 163, no. 12, pp. 1448–1453, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. Bursill, P. D. Roach, C. D. K. Bottema, and S. Pal, “Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells,” Journal of Agricultural and Food Chemistry, vol. 49, no. 11, pp. 5639–5645, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Journoud and P. J. H. Jones, “Red yeast rice: a new hypolipidemic drug,” Life Sciences, vol. 74, no. 22, pp. 2675–2683, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Heber, I. Yip, J. M. Ashley, D. A. Elashoff, R. M. Elashoff, and V. L.W. Go, “Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement,” American Journal of Clinical Nutrition, vol. 69, no. 2, pp. 231–236, 1999. View at Scopus
  41. J. Wang, Z. Lu, and Z. Lu, “Multicenter clinical trial of the serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine,” Current Therapeutic Research, vol. 58, no. 12, pp. 964–978, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Li, Y. Zhu, Y. Wang, J.-S. Zhu, J. Chang, and D. Kritchevsky, “Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterol in animal models of hypercholesterolemia,” Nutrition Research, vol. 18, no. 1, pp. 71–81, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. M.-R. Rhyu, D.-K. Kim, H.-Y. Kim, and B.-K. Kim, “Nitric oxide-mediated endothelium-dependent relaxation of rat thoracic aorta induced by aqueous extract of red rice fermented with Monascus ruber,” Journal of Ethnopharmacology, vol. 70, no. 1, pp. 29–34, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Ma, Y. Li, and Y. Li, “Constituents of red yeast rice, a traditional Chinese food and medicine,” Journal of Agricultural and Food Chemistry, vol. 48, no. 11, pp. 5220–5225, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. W. H. Ling, Q. X. Cheng, J. Ma, and T. Wang, “Red and black rice decrease atherosclerotic plaque formation and increase antioxidant status in rabbits,” Journal of Nutrition, vol. 131, no. 5, pp. 1421–1426, 2001. View at Scopus
  46. T. Oki, M. Masuda, M. Kobayashi, Y. Nishiba, S. Furuta, I. Suda, and T. Sato, “Polymeric procyanidins as radical-scavenging components in red-hulled rice,” Journal of Agricultural and Food Chemistry, vol. 50, no. 26, pp. 7524–7529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. K.-M. Ko, D. H. F. Mak, P.-Y. Chiu, and M. K. T. Poon, “Pharmacological basis of ‘Yang-invigoration’ in Chinese medicine,” Trends in Pharmacological Sciences, vol. 25, no. 1, pp. 3–6, 2004. View at Publisher · View at Google Scholar
  48. J. Sun, B. Kh Tan, S.-H. Huang, M. Whiteman, and Y.-Z. Zhu, “Effects of natural products on ischemic heart diseases and cardiovascular system,” Acta Pharmacologica Sinica, vol. 23, no. 12, pp. 1142–1151, 2002.
  49. Y. K. Lin, Z. J. Xie, M. X. Jiang, M. Yu, and S. Lin, “Effect of kangshou oral liquid on the level of blood lipids in animals,” Journal of Fujian Medical College, vol. 29, no. 3, pp. 251–253, 1995 (Chinese).
  50. X. L. Lin, Z. X. Li, Y. H. Lu, S. Xie, and Y. L. Pan, “The effect of fu fang jiang zhi fen on the experimentally induced high cholesterol in mice,” Guiyang College of Traditional Chinese Medicine Journal, vol. 21, no. 2, pp. 58–59, 1999 (Chinese).
  51. X. Luo, Y. Li, W. Fan, et al., “Experimental study on reducing effect of shexiang baoxin pill from damage of arterial wall caused by hyperlipemia,” Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe Zazhi, vol. 18, no. 8, pp. 486–489, 1998 (Chinese).
  52. X. H. Sun, S. L. Li, and G. H. Liu, “Experimental study of anti-atherosclerosis treated with herbal jiang zhi wan,” Guiyang College of Traditional Chinese Medicine Journal, vol. 14, no. 2, pp. 57–59, 1992 (Chinese).
  53. Y. Zhu, C. Li, and Y. Wang, “Effects of Xuezhikang on blood lipids and lipoprotein concentrations of rabbits and quails with hyperlipidaemia,” Zhongguo Yao xue za Zhi, vol. 30, no. 11, pp. 656–670, 1995 (Chinese).
  54. Y. Lei, K.-J. Chen, J.-G. Liu, and Y.-G. Xu, “Effect of Xuefu Zhuyu Pill on platelet activating factor expression in patients with unstable angina pectoris,” Chinese Journal of Integrative Medicine, vol. 8, no. 4, pp. 267–270, 2002.
  55. D. Shi, K. Chen, and Q. Zhang, “Effect of purified Xuefu Capsule on endothelin, nitric oxide synthetase gene expression on vascular wall in atherosclerotic rabbits,” Chinese Journal of Integrative Medicine, vol. 4, no. 2, pp. 123–125, 1998.
  56. F.-Q. Xu, L.-Z. Li, H. Xu, L.-F. Yao, K.-J. Chen, and N.-F. Shao, “Effects of Xiongshao Capsule on the function of vascular endothelium of patients with cervial atherosclerosis,” Chinese Journal of Integrative Medicine, vol. 10, no. 1, pp. 14–18, 2004.
  57. Y. Y. Gao, H. J. Shen, B. Zhang, H. Y. Jin, and R. X. Qiao, “The effect of dan ze compound on experimentally induced hypercholesterolemia and arteriosclerosis in quails,” Beijing University of Chinese Medicine Journal, vol. 17, no. 6, pp. 26–28, 1994 (Chinese).
  58. Z. Tu, X. Han, and X. Han, “Protective effects of CVPM on vascular endothelium in rats fed cholesterol diet,” Clinica Chimica Acta, vol. 333, no. 1-2, pp. 85–90, 2003. View at Publisher · View at Google Scholar
  59. G. Y. Li, H. C. Liu, and G. P. Yin, “Relationship between syndrome differentiation-typing and expression of platelet-activation molecule CD62P and CD63 on platelets in psoriatic patients,” Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe Zazhi, vol. 17, no. 7, pp. 417–418, 1997 (Chinese).